NCT03708627View on ClinicalTrials.gov

Bimatoprost as a Treatment for Graves' Orbitopathy

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

July 1, 2029

Study Completion Date

July 1, 2031

Conditions

Graves Ophthalmopathy

Interventions

DRUG

Bimatoprost Ophthalmic

Bimatoprost, aka Lumigan, one drop in one eye nightly

Trial Locations (1)

98104

RECRUITING

University of Washington, Seattle

All Listed Sponsors

lead

Johns Hopkins University

OTHER